Cargando…

Pioglitazone-Mediated Peroxisome Proliferator-Activated Receptor γ Activation Aggravates Murine Immune-Mediated Hepatitis

The nuclear receptor peroxisome proliferator-activated receptor gamma (PPARγ) regulates target gene expression upon ligand binding. Apart from its effects on metabolism, PPARγ activity can inhibit the production of pro-inflammatory cytokines by several immune cells, including dendritic cells and mac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schulte, Rike, Wohlleber, Dirk, Unrau, Ludmilla, Geers, Bernd, Metzger, Christina, Erhardt, Annette, Tiegs, Gisa, van Rooijen, Nico, Heukamp, Lukas C., Klotz, Luisa, Knolle, Percy A., Diehl, Linda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7177299/ https://www.ncbi.nlm.nih.gov/pubmed/32260486 http://dx.doi.org/10.3390/ijms21072523

Ejemplares similares

Smad7 Deficiency in Myeloid Cells Does Not Affect Liver Injury, Inflammation or Fibrosis after Chronic CCl(4) Exposure in Mice
por: Unrau, Ludmilla, et al.
Publicado: (2021)

Acute Liver Injury after CCl(4) Administration Is Independent of Smad7 Expression in Myeloid Cells
por: Endig, Jessica, et al.
Publicado: (2019)

The ADP-Ribosylation Factor 4d Restricts Regulatory T-Cell Induction via Control of IL-2 Availability
por: Geers, Bernd, et al.
Publicado: (2022)

Pathogenic T-Cell Responses in Immune-Mediated Glomerulonephritis
por: Linke, Alexandra, et al.
Publicado: (2022)

The PDL1-inducible GTPase Arl4d controls T effector function by limiting IL-2 production
por: Tolksdorf, Felix, et al.
Publicado: (2018)

Immunological functions of liver sinusoidal endothelial cells
por: Knolle, Percy A, et al.
Publicado: (2016)

The role of liver sinusoidal cells in local hepatic immune surveillance
por: Wohlleber, Dirk, et al.
Publicado: (2016)

The PPAR-gamma agonist pioglitazone protects cortical neurons from inflammatory mediators via improvement in peroxisomal function
por: Gray, Elizabeth, et al.
Publicado: (2012)

Pioglitazone, a Peroxisome Proliferator-Activated Receptor γ Agonist, Suppresses Rat Prostate Carcinogenesis
por: Suzuki, Shugo, et al.
Publicado: (2016)

Contribution of Macrophage Efferocytosis to Liver Homeostasis and Disease
por: Horst, Andrea Kristina, et al.
Publicado: (2019)

Renal-Protective Effects of the Peroxisome Proliferator-Activated Receptor-γ Agonist Pioglitazone in ob/ob Mice
por: Li, Ying, et al.
Publicado: (2019)

The Peroxisome Proliferator Activated Receptor‐γ Pioglitazone Improves Vascular Function and Decreases Disease Activity in Patients With Rheumatoid Arthritis
por: Marder, Wendy, et al.
Publicado: (2013)

Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells
por: Horst, Andrea Kristina, et al.
Publicado: (2016)

Effect of Peroxisome Proliferator-Activated Receptor Gamma Agonist (Pioglitazone) and Methotrexate on Disease Activity in Rheumatoid Arthritis (Experimental and Clinical Study)
por: Shahin, Dina, et al.
Publicado: (2011)

Pioglitazone increases VEGFR3 expression and promotes activation of M2 macrophages via the peroxisome proliferator-activated receptor γ
por: Zhang, Conghui, et al.
Publicado: (2019)

Pioglitazone modulates the proliferation and apoptosis of vascular smooth muscle cells via peroxisome proliferators-activated receptor-gamma
por: Wan, Jing, et al.
Publicado: (2014)

Peroxisome proliferator activated receptor-γ agonist pioglitazone improves vascular and metabolic dysfunction in systemic lupus erythematosus
por: Hasni, Sarfaraz, et al.
Publicado: (2022)

Sharpin Contributes to TNFα Dependent NFκB Activation and Anti-Apoptotic Signalling in Hepatocytes
por: Sieber, Sabrina, et al.
Publicado: (2012)

Enhanced 3T3-L1 Differentiation into Adipocytes by Pioglitazone Pharmacological Activation of Peroxisome Proliferator Activated Receptor-Gamma (PPAR-γ)
por: Teixeira, Catarina, et al.
Publicado: (2022)

Liver Sinusoidal Endothelial Cell-Mediated CD8 T Cell Priming Depends on Co-Inhibitory Signal Integration over Time
por: Kaczmarek, Julita, et al.
Publicado: (2014)

Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)α agonist fenofibrate and the PPARγ agonist pioglitazone
por: Syversen, Unni, et al.
Publicado: (2009)

The Peroxisome Proliferator-Activated Receptor γ Agonist Pioglitazone Protects Vascular Endothelial Function in Hypercholesterolemic Rats by Inhibiting Myeloperoxidase
por: Zhang, Dapeng, et al.
Publicado: (2020)

Effects of Pioglitazone Mediated Activation of PPAR-γ on CIDEC and Obesity Related Changes in Mice
por: Shamsi, Bilal Haider, et al.
Publicado: (2014)

Immune regulation in renal inflammation
por: Neumann, Katrin, et al.
Publicado: (2021)

Investigation of the antibacterial activity of pioglitazone
por: Masadeh, Majed M, et al.
Publicado: (2011)

Renoprotective and haemodynamic effects of adiponectin and peroxisome proliferator-activated receptor agonist, pioglitazone, in renal vasculature of diabetic Spontaneously hypertensive rats
por: Afzal, Sheryar, et al.
Publicado: (2020)

Modulatory effects of pioglitazone as a ligand for the peroxisome proliferator-activated receptor on semen quality and fertility potential of broiler breeder roosters
por: Pourazadi, Laya, et al.
Publicado: (2022)

Improving Therapeutic Vaccination against Hepatitis B—Insights from Preclinical Models of Immune Therapy against Persistent Hepatitis B Virus Infection
por: Knolle, Percy A., et al.
Publicado: (2021)

Antigen presentation, autoantibody production, and therapeutic targets in autoimmune liver disease
por: Horst, Andrea Kristina, et al.
Publicado: (2020)

The synergistic ameliorative activity of peroxisome proliferator‐activated receptor‐alpha and gamma agonists, fenofibrate and pioglitazone, on hippocampal neurodegeneration in a rat model of insulin resistance
por: Idowu, Olumayowa K., et al.
Publicado: (2022)

TNF in the liver: targeting a central player in inflammation
por: Tiegs, Gisa, et al.
Publicado: (2022)

NLRP3 Inflammasome and IL-33: Novel Players in Sterile Liver Inflammation
por: Neumann, Katrin, et al.
Publicado: (2018)

Type 2 Innate Lymphoid Cells in Liver and Gut: From Current Knowledge to Future Perspectives
por: Ochel, Aaron, et al.
Publicado: (2019)

Liver X receptor activation promotes differentiation of regulatory T cells
por: Herold, Martin, et al.
Publicado: (2017)

Activation of peroxisome proliferator activated receptor alpha ameliorates ethanol mediated liver fibrosis in mice
por: Nan, Yue-Min, et al.
Publicado: (2013)

Regulation of ENaC-Mediated Sodium Reabsorption by Peroxisome Proliferator-Activated Receptors
por: Pavlov, Tengis S., et al.
Publicado: (2010)

Peroxisome Proliferator-Activated Receptor-γ-Mediated Polarization of Macrophages in Leishmania Infection
por: Chan, Marion M., et al.
Publicado: (2012)

The co-inhibitory molecule PD-L1 contributes to regulatory T cell-mediated protection in murine crescentic glomerulonephritis
por: Neumann, Katrin, et al.
Publicado: (2019)

In Vivo Bioluminescence Imaging of HBV Replicating Hepatocytes Allows for the Monitoring of Anti-Viral Immunity
por: Manske, Katrin, et al.
Publicado: (2021)

Aggravation of Cerebral Ischemia/Reperfusion Injury by Peroxisome Proliferator-Activated Receptor-Gamma Deficiency via Endoplasmic Reticulum Stress
por: Chen, Yueping, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cq723k2er0sb5j3n70djomojrt